Published : 15 Jan 2026, 05:26 PM
Ratna Patra, a director and vice-chairman of Square Pharmaceuticals and the daughter of the company’s late founder Samson H Chowdhury, has announced plans to buy another 1 million shares of the pharmaceutical giant at the prevailing market price.
In a disclosure to investors through the Dhaka Stock Exchange (DSE) on Thursday, she said the shares would be purchased from the main market or the block market within the next 30 working days.
Under securities regulations, company directors are required to inform investors through the stock exchange before buying or selling shares.
Earlier this month, on Jan 5, Samson’s son Tapan Chowdhury, the managing director of Square Pharmaceuticals, announced his intention to buy 2 million shares of the company through the DSE.
Siblings Tapan and Ratna assumed leadership roles in the company following their father’s death.
Within a span of 10 days, the two siblings have announced plans to acquire a combined total of 3 million shares.
The latest purchases will further consolidate the control of Samson’s successors in Square Pharmaceuticals.
According to DSE data, Square Pharma shares last traded at Tk 209.80, up Tk 0.80 - or 0.38 percent - from the previous day’s closing price of Tk 209. The stock reached an intraday high of Tk 211.20 during Thursday’s session.
The company’s audited financial statements show that Square Pharmaceuticals posted a net profit of Tk 23.97 billion in the 2024–25 fiscal year. It declared a 120 percent cash dividend for shareholders.
Over the past year, the company’s shares have traded as high as Tk 232.20.